
Olympus Scope Leads
Represent patients who contracted CRE, sepsis, or other serious infections after undergoing a procedure involving an Olympus duodenoscope, cystoscope, ureteroscope, choledochoscope, or hysteroscope.
Olympus Duodenoscope & Endoscope Infection Litigation
Olympus Corp. — the manufacturer of roughly 85% of the U.S. duodenoscope market — has been tied to more than 400 confirmed superbug infections across 36+ hospitals and at least 35 deaths documented by the U.S. Senate HELP Committee. Internal communications show Olympus knew its TJF-Q180V duodenoscope design trapped bacteria as early as 2012, but concealed warnings from U.S. regulators until 2015. In January 2025, Olympus recalled the MAJ-891 endoscope tubing set after 120 reported injuries and one death. The FDA issued an import alert on 58 Olympus products in June 2025, and an Urgent Field Safety Notice followed in October 2025 citing two additional deaths and five injuries. In 2018, Olympus paid an $85 million criminal fine for failing to report device-related injuries. Case values include the landmark Bigler verdict of $6.6 million plus $250,000 in concealment sanctions. Litigation is now expanding beyond duodenoscopes to cystoscopes, ureteroscopes, choledochoscopes, and hysteroscopes.
Associated Conditions
- CRE (Carbapenem-Resistant Enterobacteriaceae) infection
- Sepsis or septic shock requiring ICU admission
- Bacteremia or bloodstream infection
- E. coli, Klebsiella, or Pseudomonas infection
- Cholangitis or post-ERCP infection
- Urinary tract infection after cystoscopy or ureteroscopy
- Wrongful death following an Olympus scope procedure
Claimant Eligibility
- Underwent a procedure using an Olympus duodenoscope, cystoscope, ureteroscope, choledochoscope, or hysteroscope (including TJF-Q180V, TJF-160F, and MAJ-891 tubing)
- Diagnosed with a bacterial infection, sepsis, or CRE within 30 days of the scope procedure
- Hospitalization, ICU admission, or extended medical treatment required as a result of the infection
- Procedure occurred at a U.S. hospital or ambulatory surgical center from 2012 onward
- Wrongful death claims accepted where the decedent died from post-procedure infection complications
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Running a Olympus Scope mass tort marketing campaign
Common questions from law firms about Olympus Scope lead generation and campaign management.
- What does a Olympus Scope mass tort marketing campaign include?
- A Olympus Scope mass tort marketing campaign from Mass Tort Marketing Agency covers channel strategy across Meta, Google/PPC, OTT, and mass tort SEO; compliant ad creative; TCPA-verified intake; claimant qualification against your Olympus Scope case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- Are Olympus Scope leads exclusive to my firm?
- Yes. Every Olympus Scope lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Olympus Scope claimants qualified before delivery?
- Each Olympus Scope claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a TrustedForm or Jornaya consent token captured under the FCC one-to-one consent standard before the lead reaches your intake team.
- How is a Olympus Scope campaign priced?
- Campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. You can scale volume up or down by tort as your docket capacity changes.
See how every lead is qualified on our mass tort leads page, or compare providers in our top mass tort marketing firms guide.